Synthetic Strategies toward Lysergic Acid Diethylamide: Ergoline Synthesis via α-Arylation, Borrowing Hydrogen Alkylation, and C-H Insertion. [PDF]
Tuck JR, Dunlap LE, Olson DE.
europepmc +1 more source
Psychedelics as Novel Therapeutics for Chronic Pain in Veterinary Medicine: A Hypothesis-Driven Protocol Using Low-Dose 1-Cyclopropionyl-D-lysergic Acid Diethylamide (1cp-LSD) in Canine Osteoarthritis. [PDF]
Hernández-Álvarez E +3 more
europepmc +1 more source
Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD). [PDF]
Brandt SD +7 more
europepmc +1 more source
The Use of Lysergic Acid in Individual Psychotherapy [PDF]
T M, LING, J, BUCKMAN
openaire +2 more sources
Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice. [PDF]
McGriff SA +5 more
europepmc +1 more source
Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide. [PDF]
Murphy RJ +6 more
europepmc +1 more source
Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine. [PDF]
Kargbo RB.
europepmc +1 more source
Use of Lysergic Acid Diethylamide by Major Depression Status. [PDF]
Walsh CA +4 more
europepmc +1 more source
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited. [PDF]
Glatfelter GC +4 more
europepmc +1 more source
Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine. [PDF]
Avram M +12 more
europepmc +1 more source

